Call for Papers — Third Issue
2026-02-14
Volume 2, Issue 2 — September 2027
United States Real-World Data Infrastructure: FDA-Aligned Sources from Claims to EHR Networks The United States remains the world's largest real-world evidence market—yet fragmentation across commercial claims databases, EHR consortia, and integrated delivery networks creates critical navigation challenges for global evidence teams. This issue maps America's RWD ecosystem through rigorous Data Resource Profiles of Optum, IBM MarketScan, TriNetX, PCORnet, Mayo Clinic, Kaiser Permanente, and specialty registries—detailing data provenance, patient attribution logic, FHIR interoperability readiness, and documented use in recent FDA submissions. Why contribute now?
✓ Your profile becomes essential reading for pharma evidence teams designing U.S.-anchored studies ahead of 2028 product launches
✓ Gain direct visibility with regulatory affairs units preparing FDA submission packages
✓ Position your source as the benchmark for FDA RWE Framework compliance as guidance updates finalize in late 2026 Submission deadline: May 15, 2027
Article Processing Charge: €1,650 (early-bird €1,350 until March 31, 2027)
United States Real-World Data Infrastructure: FDA-Aligned Sources from Claims to EHR Networks The United States remains the world's largest real-world evidence market—yet fragmentation across commercial claims databases, EHR consortia, and integrated delivery networks creates critical navigation challenges for global evidence teams. This issue maps America's RWD ecosystem through rigorous Data Resource Profiles of Optum, IBM MarketScan, TriNetX, PCORnet, Mayo Clinic, Kaiser Permanente, and specialty registries—detailing data provenance, patient attribution logic, FHIR interoperability readiness, and documented use in recent FDA submissions. Why contribute now?
✓ Your profile becomes essential reading for pharma evidence teams designing U.S.-anchored studies ahead of 2028 product launches
✓ Gain direct visibility with regulatory affairs units preparing FDA submission packages
✓ Position your source as the benchmark for FDA RWE Framework compliance as guidance updates finalize in late 2026 Submission deadline: May 15, 2027
Article Processing Charge: €1,650 (early-bird €1,350 until March 31, 2027)
